These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1233 related articles for article (PubMed ID: 1283228)
1. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case]. Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228 [TBL] [Abstract][Full Text] [Related]
2. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report. Casini M; Pianezze G; Fabris P; Cemin S; Coser P Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357 [No Abstract] [Full Text] [Related]
3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578 [TBL] [Abstract][Full Text] [Related]
4. [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793 [TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease. A historical perspective. Avilés A; Díaz-Maqueo JC; Torras V; Ayala JR; Cortés HD Arch Invest Med (Mex); 1991; 22(1):27-33. PubMed ID: 1726450 [TBL] [Abstract][Full Text] [Related]
6. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease. Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562 [TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease: controversies and challenges for the future. Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436 [No Abstract] [Full Text] [Related]
8. Hodgkin's disease and the risk of acute leukemia in successfully treated patients. Valagussa P; Bonadonna G Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571 [No Abstract] [Full Text] [Related]
9. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient. Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628 [TBL] [Abstract][Full Text] [Related]
10. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center]. Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222 [TBL] [Abstract][Full Text] [Related]
11. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute. Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481 [TBL] [Abstract][Full Text] [Related]
13. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496 [TBL] [Abstract][Full Text] [Related]
14. [Acute myeloid leukemia after treatment of Hodgkin's disease]. Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992 [TBL] [Abstract][Full Text] [Related]
15. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute. Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the risk of solid tumor following Hodgkin's disease. Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084 [TBL] [Abstract][Full Text] [Related]
18. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy]. Lira P; Grebe G Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597 [No Abstract] [Full Text] [Related]
19. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma. Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M; Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]